rs55851925
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001854.4(COL11A1):āc.1522A>Gā(p.Thr508Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,613,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T508I) has been classified as Benign.
Frequency
Consequence
NM_001854.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL11A1 | NM_001854.4 | c.1522A>G | p.Thr508Ala | missense_variant | 13/67 | ENST00000370096.9 | NP_001845.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL11A1 | ENST00000370096.9 | c.1522A>G | p.Thr508Ala | missense_variant | 13/67 | 1 | NM_001854.4 | ENSP00000359114.3 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251210Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135764
GnomAD4 exome AF: 0.000125 AC: 182AN: 1461518Hom.: 0 Cov.: 30 AF XY: 0.000118 AC XY: 86AN XY: 727068
GnomAD4 genome AF: 0.000138 AC: 21AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74314
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 04, 2023 | Identified in a patient with a clinical diagnosis of blindness in published literature (Dineiro et al., 2020); Not located in the triple helical region, where the majority of pathogenic missense variants occur (HGMD; Acke et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32483926) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 15, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.1522A>G (p.T508A) alteration is located in exon 13 (coding exon 13) of the COL11A1 gene. This alteration results from a A to G substitution at nucleotide position 1522, causing the threonine (T) at amino acid position 508 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at